Intradermal hepatitis B vaccination: A systematic review and meta-analysis

Vaccine

Volumn 27, Issue 12, 2009, Pages 1777-1786

  Sangaré, Laura ^a   Manhart, Lisa ^a   Zehrung, Darin ^b   Wang, Chia C ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PATH   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis B; Intradermal; Meta analysis

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

AGE DISTRIBUTION; ANTIBODY RESPONSE; ANTIBODY TITER; CD4 CD8 RATIO; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; HEALTH CARE PERSONNEL; HEPATITIS A VIRUS; HEPATITIS B; HUMAN; IMMUNE RESPONSE; META ANALYSIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW;

CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRADERMAL; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 61349183077     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.043     Document Type: Review

References (55)

1. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., and Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28 (2006) 112-125
2. Chen W., and Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev 4 (2005) CD000100
3. Halliday M.L., Rankin J.G., Bristow N.J., Coates R.A., Corey P.N., and Strickler A.C. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine. Arch Intern Med 150 6 (1990) 1195-1200
4. Soyletir G., Bahceci E., Akoglu E., Soyogul U., and Lawrance R.A. Clinical evaluation of low dose intradermally administered hepatitis B vaccine: a comparison of plasma-derived and recombinant yeast-derived vaccines. Vaccine 10 5 (1992) 301-304
5. Bax L., Yu L.M., Ikeda N., Tsuruta H., and Moons K.G.M. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 6 50 (2006)
6. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KGM. MIX: comprehensive free software for meta-analysis of causal research data. Version 1.7. http://mix-for-meta-analysis.info 2008.
7. Barone P., Sciacca A., Lupo F., Leonardi S., and Musumeci S. Hepatitis B vaccination in young nurses of a general hospital. Ann Ig 7 4 (1995) 251-255
8. Elavia A.J., Marfatia S.P., and Banker D.D. Immunization of hospital personnel with low-dose intradermal hepatitis B vaccine. Vaccine 12 1 (1994) 87-90
9. Sirinavin S., Muchacheap T., Khupulsup K., Inthraphuwasak W., and Petchclai B. Intradermal hepatitis B virus immunization: immunogenicity and reactogenicity. Southeast Asian J Trop Med Public Health 22 4 (1991) 577-580
10. Brink N.S., and Murray A.B. Intradermal vaccination against hepatitis B in a group of medical students. S Afr Med J 79 11 (1991) 653-654
11. Cardell K., Fryden A., and Normann B. Intradermal hepatitis B vaccination in health care workers. Response rate and experiences from vaccination in clinical practise. Scand J Infect Dis 31 2 (1999) 197-200
12. Clarke J.A., Hollinger F.B., Lewis E., Russell L.A., Miller C.H., Huntley A., et al. Intradermal inoculation with Heptavax-B. Immune response and histologic evaluation of injection sites. JAMA 262 18 (1989) 2567-2571
13. Goldwater P.N., Woodfield D.G., Ramirez A.M., and Anzimlt I.S. Intradermal, low dose, short course hepatitis B vaccination. N Z Med J 99 810 (1986) 703-705
14. Irving W.L., Alder M., Kurtz J.B., and Juel-Jensen B. Intradermal vaccination against hepatitis B. Lancet 2 8519 (1986) 1340
15. Kurugol Z., Egemen A., Erensoy S., Bilgic A., and Kutukculer N. Intradermal administration of hepatitis B vaccine in infants and preschool children. Turk J Pediatr 39 4 (1997) 483-489
16. McKee C.M., Duke P., McEvoy M.B., and Kelsey M.C. Effectiveness of intradermal hepatitis B immunization of hospital staff. Int J STD AIDS 1 1 (1990) 32-34
17. Morris C.A., Oliver P.R., Reynolds F., and Selkon J.B. Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age. Epidemiol Infect 103 2 (1989) 387-394
18. Wilkins T.D., and Cossart Y.E. Low-dose intradermal vaccination of medical and dental students. Med J Aust 152 3 (1990) 140-143
19. Herbert M., Butler A.V., Roome A.P., and Caul E.O. Comparison of intradermal and intramuscular hepatitis B vaccination in university students. Vaccine 7 5 (1989) 395-396
20. Jaiswal S.P., Asolkar M.V., Vijayvargiya R., and Chitnis D.S. Immunogenicity of low dose hepatitis B vaccine by the intradermal route & persistence of anti-HBs after three years. Indian J Med Res 102 (1995) 129-133
21. King J.W., Taylor E.M., Crow S.D., White M.C., Todd J.R., Poe M.B., et al. Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly. Rev Infect Dis 12 6 (1990) 1035-1043
22. Struve J., Aronsson B., Frenning B., Granath F., von Sydow M., and Weiland O. Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response. Scand J Infect Dis 24 4 (1992) 423-429
23. Tekeli E., Balik I., Kurt H., Kandilci S., and Senbil O. Intramuscular and intradermal administration of a recombinant hepatitis B vaccine (1995), Ankara University Medical School, Department of Infectious Disease, Ankara pp. 23-26
24. Wahl M., and Hermodsson S. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response. Scand J Infect Dis 19 6 (1987) 617-621
25. Whittle H.C., Lamb W.H., and Ryder R.W. Trials of intradermal hepatitis B vaccines in Gambian children. Ann Trop Paediatr 7 1 (1987) 6-9
26. Bryan J.P., Sjogren M., Iqbal M., Khattak A.R., Nabi S., Ahmed A., et al. Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines. J Infect Dis 162 4 (1990) 789-793
27. Coleman P.J., Shaw Jr. F.E., Serovich J., Hadler S.C., and Margolis H.S. Intradermal hepatitis B vaccination in a large hospital employee population. Vaccine 9 10 (1991) 723-727
28. Das H.S., Sawant P., Shirhatti R.G., Vyas K., Vispute S., Dhadphale S., et al. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers. Trop Gastroenterol 23 3 (2002) 120-121
29. Egemen A., Aksit S., Kurugol Z., Erensoy S., Bilgic A., and Akilli M. Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children. Vaccine 16 16 (1998) 1511-1515
30. Frazer I.H., Jones B., Dimitrakakis M., and Mackay I.R. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen. Med J Aust 146 5 (1987) 242-245
31. Ghabouli M.J., Sabouri A.H., Shoeibi N., Bajestan S.N., and Baradaran H. High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: comparison with standard intramuscular vaccination. Eur J Epidemiol 19 9 (2004) 871-875
32. Gomber S., Sharma R., and Ramachandran V.G. Immunogenicity of low dose intradermal hepatitis B vaccine and its comparison with standard dose intramuscular vaccination. Indian Pediatr 41 9 (2004) 922-926
33. Gonzalez M.L., Usandizaga M., Alomar P., Salva F., Martin F., Erroz M.J., et al. Intradermal and intramuscular route for vaccination against hepatitis B. Vaccine 8 4 (1990) 402-405
34. Halsey N.A., Reppert E.J., Margolis H.S., Francis D.P., and Fields H.A. Intradermal hepatitis B vaccination in an abbreviated schedule. Vaccine 4 4 (1986) 228-232
35. Heijtink R.A., Knol R.M., and Schalm S.W. Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes. J Med Virol 27 2 (1989) 151-154
36. Turchi M.D., Martelli C.M., Ferraz M.L., Silva A.E., Cardoso D.D., Martelli P., et al. Immunogenicity of low-dose intramuscular and intradermal vaccination with recombinant hepatitis B vaccine. Rev Inst Med Trop Sao Paulo 39 1 (1997) 15-19
37. Wistrom J., Settergren B., Gustafsson A., Juto P., and Norrby R.S. Intradermal vs intramuscular hepatitis B vaccinations. JAMA 264 2 (1990) 181-182
38. Zuberi B.F., Rajput M.R., Muzaffar L., Jatoi N., and Shaikh W.M. Efficacy of low dose intra-dermal hepatitis B vaccination schedule. J Pak Med Assoc 48 12 (1998) 377-378
39. Bryan J.P., Sjogren M.H., Perine P.L., and Legters L.J. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 14 3 (1992) 697-707
40. Hadler S.C., and Margolis H.S. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. Curr Clin Top Infect Dis 12 (1992) 282-308
41. Rivey M.P., and Peterson J. Intradermal hepatitis B vaccination. DICP 25 6 (1991) 628-634
42. Henderson E.A., Louie T.J., Ramotar K., Ledgerwood D., Hope K.M., and Kennedy A. Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers. Infect Control Hosp Epidemiol 21 4 (2000) 264-269
43. Oliveira P.M., Silva A.E., Kemp V.L., Juliano Y., and Ferraz M.L. Comparison of three different schedules of vaccination against hepatitis B in health care workers. Vaccine 13 9 (1995) 791-794
44. Parish D.C., Muecke H.W., Joiner T.A., Pope W.T., and Hadler S.C. Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine. South Med J 84 4 (1991) 426-430
45. Coursaget P, Tong MJ, editors. Studies of hepatitis B vaccine in homosexual men. Paris: John Libby Eurotext; 1990; 165 pp. Progress in Hepatitis B Immunization.
46. Wainwright R.B., McMahon B.J., Bulkow L.R., Hall D.B., Fitzgerald M.A., Harpster A.P., et al. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA 261 16 (1989) 2362-2366
47. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351 22 (2004) 2286-2294
48. Debenedictis C., Joubeh S., Zhang G., Barria M., and Ghohestani R.F. Immune functions of the skin. Clin Dermatol 19 5 (2001) 573-585
49. Kyi K.P., Oo K.M., Htun M.M., Tun W.M., Aye K.K., Oo S.S., et al. Clinical trial of the intradermal administration of hepatitis B vaccine produced at the Department of Medical Research, Myanmar. Vaccine 20 11-12 (2002) 1649-1652
50. Sangfelt P., Uhnoo I., Reichard O., and Weiland O. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting. Scand J Gastroenterol 43 4 (2008) 465-472
51. Cui Z., Baizer L., and Mumper R.J. Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device. J Biotechnol 102 2 (2003) 105-115
52. Lambert P.H., and Laurent P.E. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?. Vaccine 26 26 (2008) 3197-3208
53. Laurent P.E., Bonnet S., Alchas P., Regolini P., Mikszta J.A., Pettis R., et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25 52 (2007) 8833-8842
54. Raviprakash K., and Porter K.R. Needle-free injection of DNA vaccines: a brief overview and methodology. Methods Mol Med 127 (2006) 83-89
55. Liu Y., Mark A.F., and Kendall. Optimization of a jet-propelled particle injection system for the uniform transdermal delivery of drug/vaccine. Biotechnol Bioeng 97 5 (2007) 1300-1308